Evaluation of Ischemia Modified Albumin IMA as New Predictor in Patients with Newly Thyroid Dysfunction in Type 2 Diabetes Mellitus. Medico Legal Update, [S. l.], v. 21, n. 2, p. 1426–1431, 2021. DOI: 10.37506/mlu.v21i2.2892. Disponível em: https://ijop.net/index.php/mlu/article/view/2892. Acesso em: 9 jun. 2026.